硕肯生物硕肯生物Soken.bio
查看试用产品 →开放浏览 · 登录后申请
人 DRAXIN 抗体对
试剂盒

人 DRAXIN 抗体对

01AB01108

Dorsal inhibitory axon guidance protein (DRAXIN) is a secreted, 58 kDa glycosylated protein primarily expressed in the developing brain and spinal cord, where it functions as a chemorepulsive axon guidance molecule essential for neural circuit formation, including the spinal cord commissure, corpus callosum, and thalamocortical projections. Structurally, DRAXIN contains a signal sequence, a mature domain with a cysteine-rich region, and shares similarities with the DKK family of Wnt inhibitors, acting as a Wnt antagonist by binding to LRP6. It interacts with receptors such as DCC and Neo1, influencing axon pathfinding by inhibiting or repelling neurite outgrowth from dorsal spinal cord neurons and regulating the remodeling of midline structures necessary for commissural axon crossing. Disruption of DRAXIN function has been linked to abnormal neural development, particularly affecting the formation of the corpus callosum, which can result in neurodevelopmental disorders due to impaired axon guidance and midline crossing.

Human
规格起售价
登录后可查看

技术参数

靶点基因名
DRAXIN
基因别名
C1orf187
蛋白别名
dorsal inhibitory axon guidance protein; DRAXIN
UniProt
Q8NBI3
物种
Human

产品详情

靶点名称
DRAXIN
蛋白名称
dorsal inhibitory axon guidance protein
蛋白别名
Draxin; Dorsal inhibitory axon guidance protein; Dorsal repulsive axon guidance protein; Neucrin
靶点基因名
DRAXIN
基因别名
C1orf187
UniProt
Q8NBI3
来源物种
Homo sapiens (Human)
物种反应性
Human

背景介绍

Dorsal inhibitory axon guidance protein (DRAXIN) is a secreted, 58 kDa glycosylated protein primarily expressed in the developing brain and spinal cord, where it functions as a chemorepulsive axon guidance molecule essential for neural circuit formation, including the spinal cord commissure, corpus callosum, and thalamocortical projections. Structurally, DRAXIN contains a signal sequence, a mature domain with a cysteine-rich region, and shares similarities with the DKK family of Wnt inhibitors, acting as a Wnt antagonist by binding to LRP6. It interacts with receptors such as DCC and Neo1, influencing axon pathfinding by inhibiting or repelling neurite outgrowth from dorsal spinal cord neurons and regulating the remodeling of midline structures necessary for commissural axon crossing. Disruption of DRAXIN function has been linked to abnormal neural development, particularly affecting the formation of the corpus callosum, which can result in neurodevelopmental disorders due to impaired axon guidance and midline crossing.